FLUTICASON Mepha spray nasal 27.5 mcg 120 dos
7680693120013
CH-69312
R01AD12
12.02.3.
1 / 3
google
Details
- Product number
- 6931201
- CPT
- -
- Packaging group
- 120
- Unit
- Einzeldose(n)
- Composition
- fluticasoni furoas 27.5 µg, cellulosum microcristallinum et carmellosum natricum, polysorbatum 80, dinatrii edetas, glucosum, benzalkonii chloridum 8.25 µg, aqua ad iniectabile ad suspensionem pro dosi, doses pro vase 120.
Articles (1)
Fluticason-Mepha 27.5 μg, Nasenspray, Suspension
Nasenspray
120
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
27.5 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
8.25 UG | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 16.70
Specialties list
Yes
Generic
Yes
SL addition date:
01/01/2025
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 69312
- Drug name
- Fluticason-Mepha, Nasenspray, Suspension
- Galenic form
- NASSS
- ATC Code
- R01AD12
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 18/07/2024
- Authorization expiration date
- 17/07/2029
- IT number
- 12.02.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FLUTICASON Mepha spray nasal 27.5 mcg 120 dos
- Description (DE)
- FLUTICASON Mepha Nasenspray 27.5 mcg 120 Dos
- Market launch
- 18/07/2024
- Narcotic (BTM)
- No